← ANALYSTS · TIPRANKS

Andrew Fein · H.C. Wainwright

#267among 12,504 TipRanks analysts★★★★★★★★★★
Hits 52% 257 of 494 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating +23.7% Over a year after the rating, TipRanks’ measure
Our companies rated now 21 Buy / hold / sell: 19 / 2 / 0
Upside of the analyst’s targets +128.2% Average over 21 current targets, to the last price
The market’s answer to the ratings +6.7% Day-0 move against SPY in the rating’s direction, average over 8 upgrades, downgrades and target changes
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Oct 15on TipRanks 06:20 LQDAIWMLiquidia Technologies · $3.1B Reiterated Buy $58.00 → $65.00+12.1% +89.2% +2.2%next day −0.1%
Oct 14on TipRanks 11:55 ALECIWMAlector · $213M Reiterated Buy $5.00 → $8.00+60.0% +334.8% +1.6%next day +1.3%
Oct 12on TipRanks 07:45 INSMInsmed · $21.5B Reiterated Buy $220 +128.5% −2.0%next day −1.8%
Oct 12on TipRanks 06:30 PVLAIWMPalvella Therapeutics · $1.8B Reiterated Buy $270 → $246−8.9% +104.5% −3.1%next day −4.4%
Oct 8on TipRanks Oct 9 08:01 MDGLMadrigal Pharmaceuticals · $10.4B Reiterated Buy $620 +37.9% −1.8%next day −1.7% · 5 days −3.3%
Oct 2on TipRanks 06:55 WVEIWMWave Life Sciences · $629M Reiterated Buy $13.00 +315.3% −3.3%next day −1.5% · 5 days −9.6%
Sep 30on TipRanks 06:20 DYNIWMDyne Therapeutics · $2.9B Reiterated Buy $50.00 → $32.00−36.0% +124.6% −0.4%next day −2.0% · 5 days −2.8%
Sep 24on TipRanks 06:25 ARCTIWMArcturus Therapeutics · $320M Reiterated Hold $9.00 −13.0% +6.2%next day −2.5% · 5 days −6.0%
Sep 22on TipRanks 10:25 VRTXQQQSPYVertex Pharmaceuticals · $129B Reiterated Buy $641 +28.3% +0.9%next day +1.0% · 5 days +3.5%
Sep 21on TipRanks Sep 22 05:45 DBVTDBV Technologies SA - American · $719M Reiterated Buy $40.00 +342.0% −3.6%next day +4.4% · 5 days −2.8%
Aug 20on TipRanks Aug 18 12:25 AMLXIWMAmylyx Pharmaceuticals Inc · $3.4B Reiterated Buy $34.00 → $55.00+61.8% +108.8% +64.5%next day +9.7% · 5 days +6.9%
Aug 12on TipRanks 06:35 SVRAIWMSavara · $974M Reiterated Buy $10.00 +124.7% +2.1%next day −8.2% · 5 days −1.7%
Aug 7on TipRanks 15:05 DNLIIWMDenali Therapeutics · $2.9B Reiterated Buy $42.00 +138.5% −0.2%next day +0.7% · 5 days −2.1%
Aug 7on TipRanks 06:45 PRTAIWMProthena · $436M Reiterated Buy $30.00 +259.3% +1.5%next day +4.1% · 5 days +0.7%
Aug 6on TipRanks 15:05 UTHRUnited Therapeutics · $23.3B Reiterated Buy $660 +23.8% +2.8%next day +0.5% · 5 days −7.2%
Aug 6on TipRanks 14:07 BCRXIWMBioCryst · $2.0B Reiterated Buy $32.00 +310.8% +2.7%next day +0.2% · 5 days +4.3%
Aug 6on TipRanks 06:35 KYMRIWMKymera Therapeutics · $9.0B Reiterated Buy $134 +27.9% +1.0%next day +0.4% · 5 days +6.3%
Aug 5on TipRanks 13:35 ARVNIWMArvinas Holding Company · $468M Reiterated Buy $18.00 +158.2% −6.5%next day +3.5% · 5 days +5.2%
Jul 31on TipRanks 12:46 NBIXNeurocrine · $13.9B Reiterated Buy $215 +58.4% −10.8%next day −1.8% · 5 days −5.5%
Jul 30on TipRanks 10:49 BIIBSPYBiogen · $34.8B Reiterated Buy $237 → $251+5.9% +7.9% −2.3%next day −3.1% · 5 days −4.4%
Jun 2on TipRanks 06:30 FULCIWMFulcrum Therapeutics · $280M Downgrade Hold $25.00 → $3.00−88.0% −17.8% −51.2%next day +3.2% · 5 days +15.1%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗